chr4-56467653-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_006947.4(SRP72):​c.18C>G​(p.Ser6Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000645 in 1,550,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S6T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000050 ( 0 hom. )

Consequence

SRP72
NM_006947.4 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.01

Publications

0 publications found
Variant links:
Genes affected
SRP72 (HGNC:11303): (signal recognition particle 72) This gene encodes the 72 kDa subunit of the signal recognition particle (SRP), a ribonucleoprotein complex that mediates the targeting of secretory proteins to the endoplasmic reticulum (ER). The SRP complex consists of a 7S RNA and 6 protein subunits: SRP9, SRP14, SRP19, SRP54, SRP68, and SRP72, that are bound to the 7S RNA as monomers or heterodimers. SRP has at least 3 distinct functions that can be associated with the protein subunits: signal recognition, translational arrest, and ER membrane targeting by interaction with the docking protein. Mutations in this gene are associated with familial bone marrow failure. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
SRP72 Gene-Disease associations (from GenCC):
  • autosomal dominant aplasia and myelodysplasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • acute myeloid leukemia
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.066376925).
BS2
High AC in GnomAdExome4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SRP72NM_006947.4 linkc.18C>G p.Ser6Arg missense_variant Exon 1 of 19 ENST00000642900.1 NP_008878.3 O76094-1V9HWK0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRP72ENST00000642900.1 linkc.18C>G p.Ser6Arg missense_variant Exon 1 of 19 NM_006947.4 ENSP00000495128.1 O76094-1

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151404
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000512
AC:
1
AN:
195388
AF XY:
0.00000920
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000110
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000500
AC:
7
AN:
1399354
Hom.:
0
Cov.:
29
AF XY:
0.00000432
AC XY:
3
AN XY:
694704
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29592
American (AMR)
AF:
0.00
AC:
0
AN:
35234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24186
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34008
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80204
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51538
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5576
European-Non Finnish (NFE)
AF:
0.00000647
AC:
7
AN:
1081604
Other (OTH)
AF:
0.00
AC:
0
AN:
57412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151404
Hom.:
0
Cov.:
31
AF XY:
0.0000271
AC XY:
2
AN XY:
73924
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41202
American (AMR)
AF:
0.00
AC:
0
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5114
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67900
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 23, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.S6R variant (also known as c.18C>G), located in coding exon 1 of the SRP72 gene, results from a C to G substitution at nucleotide position 18. The serine at codon 6 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.66
BayesDel_addAF
Benign
-0.098
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Benign
0.029
T;.;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.22
T;T;.;T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.066
T;T;T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.90
L;L;L;.
PhyloP100
-1.0
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.3
N;N;.;.
REVEL
Benign
0.21
Sift
Uncertain
0.019
D;D;.;.
Sift4G
Benign
0.094
T;T;.;D
Polyphen
0.31
B;.;B;.
Vest4
0.12
MutPred
0.36
Loss of glycosylation at S6 (P = 7e-04);Loss of glycosylation at S6 (P = 7e-04);Loss of glycosylation at S6 (P = 7e-04);Loss of glycosylation at S6 (P = 7e-04);
MVP
0.43
MPC
0.27
ClinPred
0.14
T
GERP RS
-2.6
PromoterAI
-0.069
Neutral
Varity_R
0.21
gMVP
0.13
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs777589749; hg19: chr4-57333819; API